Journal article icon

Journal article : Review

What have we learned from animal studies of immune responses to respiratory syncytial virus infection?

Abstract:
Respiratory syncytial virus (RSV) is a common cause of severe respiratory tract infection at the extremes of age and in vulnerable populations. However, it is difficult to predict the clinical course and most infants who develop severe disease have no pre-existing risk factors. With the recent licencing of RSV vaccines and monoclonal antibodies, it is important to identify high-risk individuals in order to prioritise those who will most benefit from prophylaxis. The immune response to RSV and the mechanisms by which the virus prevents the establishment of immunological memory have been extensively investigated but remain incompletely characterised. In animal models, beneficial and harmful immune responses have both been demonstrated. While only chimpanzees are fully permissive for human RSV replication, most research has been conducted in rodents, or in calves infected with bovine RSV. Based on these studies, components of innate and adaptive immune systems, cytokines, chemokines and metabolites, and specific genetic and transcriptomic signatures are identified as potential predictive indicators of RSV disease severity. These findings may inform the development of future human studies and contribute to the early identification of patients at high risk of severe infection. This narrative review summarises the factors involved in the immune response to RSV infection in these models and highlights the relationship between potential biomarkers and disease severity.
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.jcv.2024.105731

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Role:
Author
ORCID:
0000-0002-6350-6557
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Paediatrics
Role:
Author

Contributors

Role:
Contributor


More from this funder
Funder identifier:
https://ror.org/043cec594


Publisher:
Elsevier
Journal:
Journal of Clinical Virology More from this journal
Volume:
175
Article number:
105731
Place of publication:
Netherlands
Publication date:
2024-09-22
Acceptance date:
2024-09-18
DOI:
EISSN:
1873-5967
ISSN:
1386-6532
Pmid:
39368446


Language:
English
Keywords:
Subtype:
Review
Pubs id:
2036945
Local pid:
pubs:2036945
Deposit date:
2024-10-15

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP